Royalty during Royalty Term Sample Clauses

Royalty during Royalty Term. In further consideration of the Licenses and the Purchase Option, SalesLogix agrees to make royalty payments ("Royalties") to Symantec during the Royalty Term, equal to: - 40% of the Consolidated Revenue for each calendar quarter during the period beginning on the Closing Date and ending on December 31, 2000; - 35% of the Consolidated Revenue for each calendar quarter during the period beginning on January 1, 2001 and ending on December 31, 2001; - 30% of the Consolidated Revenue for each calendar quarter during the period beginning on January 1, 2002 and ending on December 31, 2002; and - 25% of the Consolidated Revenue for each calendar quarter during the period beginning on January 1, 2003 and ending on December 31, 2003. Notwithstanding the foregoing formula, SalesLogix shall not be required to pay Royalties to Symantec hereunder in excess of the following aggregate cumulative Royalties as of the relevant calendar quarter end dates: Quarter Ending Max. Cum. Royalties Quarter Ending Max Cum. Royalties -------------- ------------------- -------------- ------------------ March 31, 2000 $5,000,000 March 31, 2002 $39,750,000 June 30, 2000 $10,000,000 June 30, 2002 $42,500,000 September 30, 2000 $15,000,000 September 30, 2002 $45,250,000 December 31, 2000 $20,000,000 December 31, 2002 $48,000,000 March 31, 2001 $24,250,000 March 31,2003 $50,250,000 June 30, 2001 $28,500,000 June 30, 2003 $52,500,000 September 30, 2001 $32,750,000 September 30, 2003 $54,750,000 December 31, 2001 $37,000,000 December 31, 2003 $57,000,000
Sample 1
AutoNDA by SimpleDocs
Royalty during Royalty Term. In further consideration of the Licenses and the Purchase Option, SalesLogix agrees to make royalty payments ("Royalties") to Symantec during the Royalty Term, equal to: - 40% of the Consolidated Revenue for each calendar quarter during the period beginning on the Closing Date and ending on December 31, 2000;
Sample 1

Related to Royalty during Royalty Term

  • Royalty Term Licensee shall have no obligation to pay any royalty with respect to Net Sales of any Licensed Product in any country after the Royalty Term for such Licensed Product in such country has expired.

  • Royalty Period The royalty payments set forth above shall be payable for each Licensed Product on a product-by-product and country-by-country basis from the time of First Commercial Sale of Licensed Product in such country until the later of (i) [**] years from the time of First Commercial Sale of Licensed Product in such country or (ii) until the last to expire patent containing a Valid Claim providing marketing exclusivity with respect to such Licensed Product.

  • Know-How Royalty Notwithstanding the provisions of Section 5.4.1(a), in countries where the sale of Product by Merck or its Related Parties would not infringe a Valid Patent Claim, Merck shall pay royalty rates that shall be set at [***] of the applicable royalty rate determined according to Section 5.4.1(a). Such royalties shall be calculated after first calculating royalties under Section 5.4.1(a).

  • Royalty Rate Royalties shall be computed at the rate of six percent (6%) of Licensee's Net Sales during the applicable quarterly period.

  • Net Sales The term “

  • Running Royalties Company shall pay to JHU a running royalty as set forth in Exhibit A, for each LICENSED PRODUCT(S) sold, and for each LICENSED SERVICE(S) provided, by Company or AFFILIATED COMPANIES, based on NET SALES and NET SERVICE REVENUES for the term of this Agreement. Such payments shall be made quarterly. All non-US taxes related to LICENSED PRODUCT(S) or LICENSED SERVICE(S) sold under this Agreement shall be paid by Company and shall not be deducted from royalty or other payments due to JHU. In order to insure JHU the full royalty payments contemplated hereunder, Company agrees that in the event any LICENSED PRODUCT(S) shall be sold to an AFFILIATED COMPANY or SUBLICENSEE(S) or to a corporation, firm or association with which Company shall have any agreement, understanding or arrangement with respect to consideration (such as, among other things, an option to purchase stock or actual stock ownership, or an arrangement involving division of profits or special rebates or allowances) the royalties to be paid hereunder for such LICENSED PRODUCT(S) shall be based upon the greater of: 1) the net selling price (per NET SALES) at which the purchaser of LICENSED PRODUCT(S) resells such product to the end user, 2) the NET SERVICE REVENUES received from using the LICENSED PRODUCT(S) in providing a service, or 3) the net selling price (per NET SALES) of LICENSED PRODUCT(S) paid by the purchaser. No multiple royalties shall be due or payable because any LICENSED PRODUCT(S) or LICENSED SERVICE(S) is covered by more than one claim of the PATENT RIGHTS or by claims of both the PATENT RIGHTS under this Agreement and “PATENT RIGHTS” under any other license agreement between Company and JHU. The royalty shall not be cumulative based on the number of patents or claims covering a product or service, but rather shall be capped at the rate set forth in Exhibit A.

  • Minimum Royalty At the beginning of each calendar year during the term of this Agreement, beginning January 1, 2016, Company shall pay to Medical School a minimum royalty of {***}. If the actual royalty payments to Medical School in any calendar year are less than the minimum royalty payment required for that year, Company shall have the right to pay Medical School the difference between the actual royalty payment and the minimum royalty payment in full satisfaction of its obligations under this Section, provided such minimum payment is made to Medical School within sixty (60) days after the conclusion of the calendar year. Waiver of any minimum royalty payment by Medical School shall not be construed as a waiver of any subsequent minimum royalty payment. If Company fails to make any minimum royalty payment within the sixty-day period, such failure shall constitute a material breach of its obligations under this Agreement, and Medical School shall have the right to terminate this Agreement in accordance with Section 8.3.

  • Earned Royalty In addition, Alnylam will pay Stanford earned royalties on Net Sales as follows:

  • Royalty Fee The Licensee agrees to pay AmericaTowne a monthly fee equal to 7.5% of its Gross Retail Sales (the "Royalty Fee").

  • Royalty Payments (i) Royalties shall accrue when Licensed Products are invoiced, or if not invoiced, when delivered to a third party or Affiliate.

Time is Money Join Law Insider Premium to draft better contracts faster.